Parallel Advisors LLC Sells 6,797 Shares of Danaher Corporation $DHR

Parallel Advisors LLC lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 33.1% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 13,731 shares of the conglomerate’s stock after selling 6,797 shares during the quarter. Parallel Advisors LLC’s holdings in Danaher were worth $2,603,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the stock. Main Street Group LTD bought a new position in shares of Danaher during the 1st quarter valued at approximately $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the 4th quarter worth approximately $26,000. WFA of San Diego LLC purchased a new position in Danaher in the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher in the fourth quarter valued at approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on DHR shares. DZ Bank started coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Guggenheim dropped their price target on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Barclays cut their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. The Goldman Sachs Group lowered their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Finally, HSBC lowered their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $231.64.

Danaher News Roundup

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher posted Q2 adjusted EPS of $1.94, above the $1.84 consensus, and revenue of about $6.26 billion to $6.3 billion, also ahead of estimates. Danaher Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised full-year adjusted EPS guidance, showing confidence in profitability despite the softer sales backdrop. Danaher Corp (DHR) Q2 2026 Earnings Call Highlights
• Neutral Sentiment: Life Sciences was a bright spot, with stronger sales growth, but bioprocessing revenue came in weaker than expected and was cited as a drag on sentiment. Reuters: Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise
• Negative Sentiment: Investors reacted negatively to the reduced core revenue growth outlook and cautious near-term guidance, which outweighed the earnings beat and led to the stock decline. Danaher stock slips despite Q2 earnings beat, raised guidance
• Negative Sentiment: Analysts also highlighted “surprisingly soft” bioprocessing sales, reinforcing concerns that growth may slow more than expected. Danaher Plummets After One Segment Comes In ‘Surprisingly Soft’

Danaher Trading Down 11.0%

Shares of DHR opened at $179.01 on Wednesday. The business’s 50-day moving average price is $184.22 and its 200-day moving average price is $197.69. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market cap of $126.70 billion, a PE ratio of 34.62, a P/E/G ratio of 2.48 and a beta of 0.79. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.10. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.11 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 earnings per share. On average, equities analysts forecast that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is currently 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.